IL283778A - Anellosomes for delivering secreted therapeutic modalities - Google Patents
Anellosomes for delivering secreted therapeutic modalitiesInfo
- Publication number
- IL283778A IL283778A IL283778A IL28377821A IL283778A IL 283778 A IL283778 A IL 283778A IL 283778 A IL283778 A IL 283778A IL 28377821 A IL28377821 A IL 28377821A IL 283778 A IL283778 A IL 283778A
- Authority
- IL
- Israel
- Prior art keywords
- analosomes
- delivery
- therapeutic modalities
- secreted therapeutic
- secreted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals
- A61K9/5184—Virus capsids or envelopes enclosing drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00041—Use of virus, viral particle or viral elements as a vector
- C12N2750/00042—Use of virus, viral particle or viral elements as a vector virus or viral particle as vehicle, e.g. encapsulating small organic molecule
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/00041—Use of virus, viral particle or viral elements as a vector
- C12N2750/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Botany (AREA)
- Nanotechnology (AREA)
- Optics & Photonics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862778866P | 2018-12-12 | 2018-12-12 | |
| US201862778869P | 2018-12-12 | 2018-12-12 | |
| PCT/US2019/065919 WO2020123773A2 (en) | 2018-12-12 | 2019-12-12 | Anellosomes for delivering secreted therapeutic modalities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL283778A true IL283778A (en) | 2021-07-29 |
Family
ID=69160343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL283778A IL283778A (en) | 2018-12-12 | 2021-06-07 | Anellosomes for delivering secreted therapeutic modalities |
Country Status (11)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11624061B2 (en) | 2017-04-28 | 2023-04-11 | Agrospheres, Inc. | Compositions and methods for enzyme immobilization |
| BR112020005803A2 (pt) | 2017-09-25 | 2020-12-01 | Agrospheres, Inc. | composições e métodos para produção e administração moduláveis de produtos biológicos |
| JP2022513459A (ja) * | 2018-12-12 | 2022-02-08 | フラッグシップ パイオニアリング イノベーションズ ブイ, インコーポレイテッド | タンパク質代替治療モダリティを送達するためのアネロソーム |
| CA3121528A1 (en) | 2018-12-12 | 2020-06-18 | Flagship Pioneering Innovations V, Inc. | Anellosomes and methods of use |
| KR20230041686A (ko) * | 2020-06-17 | 2023-03-24 | 플래그쉽 파이어니어링 이노베이션스 브이, 인크. | 아넬로바이러스를 확인 및 특징화하는 방법 및 이의 용도 |
| US20240000914A1 (en) * | 2020-10-29 | 2024-01-04 | Flagship Pioneering Innovations V, Inc. | Chicken anemia virus (cav)-based vectors |
| WO2022170195A1 (en) * | 2021-02-08 | 2022-08-11 | Flagship Pioneering Innovations V, Inc. | Hybrid aav-anellovectors |
| EP4337235A4 (en) * | 2021-05-12 | 2025-07-02 | Flagship Pioneering Innovations V Inc | ANELLOVECTORS AND METHODS OF USE |
| CN118284411A (zh) * | 2021-10-12 | 2024-07-02 | 旗舰先锋创新V股份有限公司 | 新颖的指环载体组合物和方法 |
| MX2024004492A (es) * | 2021-10-12 | 2024-05-31 | Flagship Pioneering Innovations V Inc | Composiciones y metodos de anellovector novedosos. |
| TW202430215A (zh) | 2022-12-14 | 2024-08-01 | 美商旗艦先鋒創新有限責任(Vii)公司 | 用於將治療劑遞送至骨之組成物和方法 |
| TW202529819A (zh) | 2023-10-13 | 2025-08-01 | 美商旗艦先鋒創新公司 | 組織特異性指環載體(anellovector)遞送 |
| CN117695410B (zh) * | 2024-02-06 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | CRISPR/Cas9纳米抗菌剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6395472B1 (en) * | 1999-02-05 | 2002-05-28 | Abbott Laboratories | Methods of utilizing the TT virus |
| CN111206032B (zh) * | 2013-12-12 | 2024-07-19 | 布罗德研究所有限公司 | 用于基因组编辑的crispr-cas系统和组合物的递送、用途和治疗应用 |
| EP3359663A4 (en) * | 2015-09-24 | 2019-08-14 | The Trustees of The University of Pennsylvania | COMPOSITION AND METHOD FOR THE TREATMENT OF A COMPLEMENT-MEDIATED DISEASE |
| CA3066750A1 (en) * | 2017-06-13 | 2018-12-20 | Flagship Pioneering Innovations V, Inc. | Compositions comprising curons and uses thereof |
| KR20200067195A (ko) * | 2017-10-18 | 2020-06-11 | 리젠엑스바이오 인크. | 완전-인간 번역후 변형된 항체 치료제 |
-
2019
- 2019-12-12 US US17/413,207 patent/US20230048858A1/en not_active Abandoned
- 2019-12-12 JP JP2021533524A patent/JP2022512395A/ja active Pending
- 2019-12-12 CN CN201980091251.6A patent/CN113631717A/zh active Pending
- 2019-12-12 AU AU2019396520A patent/AU2019396520A1/en not_active Abandoned
- 2019-12-12 KR KR1020217021775A patent/KR20210131309A/ko not_active Ceased
- 2019-12-12 BR BR112021009379-6A patent/BR112021009379A2/pt unknown
- 2019-12-12 CA CA3119531A patent/CA3119531A1/en active Pending
- 2019-12-12 EP EP19836323.6A patent/EP3894568A2/en active Pending
- 2019-12-12 WO PCT/US2019/065919 patent/WO2020123773A2/en not_active Ceased
- 2019-12-12 MX MX2021006943A patent/MX2021006943A/es unknown
-
2021
- 2021-06-07 IL IL283778A patent/IL283778A/en unknown
-
2024
- 2024-05-22 JP JP2024083619A patent/JP2024100936A/ja active Pending
-
2025
- 2025-06-17 US US19/240,368 patent/US20260009050A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3894568A2 (en) | 2021-10-20 |
| CN113631717A (zh) | 2021-11-09 |
| JP2022512395A (ja) | 2022-02-03 |
| WO2020123773A9 (en) | 2020-08-27 |
| CA3119531A1 (en) | 2020-06-18 |
| BR112021009379A2 (pt) | 2021-08-17 |
| WO2020123773A3 (en) | 2020-07-23 |
| US20260009050A1 (en) | 2026-01-08 |
| MX2021006943A (es) | 2021-11-17 |
| JP2024100936A (ja) | 2024-07-26 |
| WO2020123773A2 (en) | 2020-06-18 |
| AU2019396520A1 (en) | 2021-05-27 |
| US20230048858A1 (en) | 2023-02-16 |
| KR20210131309A (ko) | 2021-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3873530A4 (en) | THERAPEUTIC PROCESSES | |
| PL3600309T3 (pl) | Skojarzenia terapeutyczne do leczenia chorób wątroby | |
| IL272410A (en) | Cytokine conjugates for the treatment of autoimmune diseases | |
| EP3866896A4 (en) | PATIENT INTERFACE | |
| EP4321197C0 (en) | PATIENT INTERFACE | |
| EP3840809A4 (en) | PATIENT INTERFACE | |
| PL3416631T3 (pl) | Środki terapeutyczne do leczenia chorób neurodegeneracyjnych | |
| IL283771A (en) | Anellosomes for delivering intracellular therapeutic modalities | |
| LT4331584T (lt) | Lanifibranoro deuterintų darinių terapietiniai naudojimai | |
| EP3636305A4 (en) | MEDICAL NEBULIZER | |
| EP3750553A4 (en) | THERAPEUTIC FOR PSORIASIS | |
| IL282330A (en) | Therapeutic compounds | |
| EP3735463A4 (en) | Cytotoxicity-inducing therapeutic agent | |
| IL281244A (en) | Combination therapy for the treatment of liver disease | |
| HUE059638T2 (hu) | Ízületi gyulladásos betegségek kombinált kezelése | |
| EP3630103C0 (en) | COMBINATION TREATMENT OF NEUROPSYCHIATRIC DISORDERS RESPONSIVE TO NMDAR ANTAGONISTS | |
| EP4028123A4 (en) | DELIVERY OF THERAPEUTIC NEUROMODULATION | |
| IL283069A (en) | Methods for administering corticosteroids | |
| EP3607963A4 (en) | THERAPEUTIC MEDICINAL FOR FIBROUS DISEASE | |
| EP3773844A4 (en) | PATIENT INTERFACE | |
| EP3860585A4 (en) | Therapeutic compositions | |
| EP3886912A4 (en) | DENDRIMER FOR THERAPY AND IMAGING | |
| EP3762079A4 (en) | PATIENT INTERFACE | |
| IL281869A (en) | Therapeutic agent for neurodegenerative disease | |
| PL3697399T3 (pl) | Środki terapeutyczne do zastosowania w leczeniu zespołu niespokojnych nóg |